Adapting an integrated acute respiratory infections sentinel surveillance to the COVID-19 pandemic requirements, Egypt, 2020-2022
© 2023 The Authors..
Objectives: In Egypt, an integrated surveillance for acute respiratory infections (ARIs) was established in 2016 to identify the causes of ARIs. The surveillance system includes 19 governmental hospitals. In response to the coronavirus disease 2019 (COVID-19) pandemic, the World Health Organisation (WHO) requested surveillance adaptation to address the emerging challenges. This study aims to describe the experience in Egypt of adapting ARI surveillance to the COVID-19 pandemic.
Methods: WHO case definitions were used to identify patients with ARIs. Nasopharyngeal/oropharyngeal swabs were collected for SARS-CoV-2 and influenza testing. Demographic and clinical information were obtained by interviewing patients at the hospitals. During the COVID-19 pandemic, the first two outpatients daily and every fifth admitted patient were enrolled in the study. To determine the status of ARIs in Egypt during the pandemic, patient demographic, clinical and laboratory data from 2020 to 2022 were obtained and descriptive analyses were performed.
Results: Overall, 18,160 patients were enrolled in the study, including 7923 (43.6%) seen at outpatient clinics and 10,237 (56.4%) inpatients. Of the study participants, 6453 (35.5%) tested positive for ARIs, including 5620 (87.1%) for SARS-CoV-2, 781 (12.1%) for influenza and 52 (0.8%) for SARS-CoV-2/influenza coinfection. SARS-CoV-2 was the cause for 95.3% of admitted patients and 65.4% of outpatients. Influenza subtypes included A/H3 (55.7%), Influenza-B (29.1%) and H1/pdm09 (14.2%). Compared with influenza, SARS-CoV-2 tended to infect the elderly, in warm weather and in urban governorates, and resulted in more hospitalisations, longer hospital stays and higher case fatalities (16.3% vs 6.6%, p < 0.001).
Conclusions: ARI surveillance in Egypt was successfully adapted to the COVID-19 pandemic and effectively described the clinical characteristics and severity of circulating viruses. Surveillance reported the re-emergence of influenza with a severe course and high fatality. Surveillance is essential for monitoring the activity of respiratory viruses with the aim of guiding clinical management, including preventative and control measures.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
Public health in practice (Oxford, England) - 5(2023) vom: 03. Juni, Seite 100358 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fahim, Manal [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute respiratory diseases |
|---|
| Anmerkungen: |
Date Revised 01.02.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.puhip.2023.100358 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351976914 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351976914 | ||
| 003 | DE-627 | ||
| 005 | 20231226052656.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.puhip.2023.100358 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1173.xml |
| 035 | |a (DE-627)NLM351976914 | ||
| 035 | |a (NLM)36686982 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fahim, Manal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adapting an integrated acute respiratory infections sentinel surveillance to the COVID-19 pandemic requirements, Egypt, 2020-2022 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. | ||
| 520 | |a Objectives: In Egypt, an integrated surveillance for acute respiratory infections (ARIs) was established in 2016 to identify the causes of ARIs. The surveillance system includes 19 governmental hospitals. In response to the coronavirus disease 2019 (COVID-19) pandemic, the World Health Organisation (WHO) requested surveillance adaptation to address the emerging challenges. This study aims to describe the experience in Egypt of adapting ARI surveillance to the COVID-19 pandemic | ||
| 520 | |a Methods: WHO case definitions were used to identify patients with ARIs. Nasopharyngeal/oropharyngeal swabs were collected for SARS-CoV-2 and influenza testing. Demographic and clinical information were obtained by interviewing patients at the hospitals. During the COVID-19 pandemic, the first two outpatients daily and every fifth admitted patient were enrolled in the study. To determine the status of ARIs in Egypt during the pandemic, patient demographic, clinical and laboratory data from 2020 to 2022 were obtained and descriptive analyses were performed | ||
| 520 | |a Results: Overall, 18,160 patients were enrolled in the study, including 7923 (43.6%) seen at outpatient clinics and 10,237 (56.4%) inpatients. Of the study participants, 6453 (35.5%) tested positive for ARIs, including 5620 (87.1%) for SARS-CoV-2, 781 (12.1%) for influenza and 52 (0.8%) for SARS-CoV-2/influenza coinfection. SARS-CoV-2 was the cause for 95.3% of admitted patients and 65.4% of outpatients. Influenza subtypes included A/H3 (55.7%), Influenza-B (29.1%) and H1/pdm09 (14.2%). Compared with influenza, SARS-CoV-2 tended to infect the elderly, in warm weather and in urban governorates, and resulted in more hospitalisations, longer hospital stays and higher case fatalities (16.3% vs 6.6%, p < 0.001) | ||
| 520 | |a Conclusions: ARI surveillance in Egypt was successfully adapted to the COVID-19 pandemic and effectively described the clinical characteristics and severity of circulating viruses. Surveillance reported the re-emergence of influenza with a severe course and high fatality. Surveillance is essential for monitoring the activity of respiratory viruses with the aim of guiding clinical management, including preventative and control measures | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Acute respiratory diseases | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Egypt | |
| 650 | 4 | |a Influenza viruses | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Sentinel surveillance | |
| 700 | 1 | |a Abu ElSood, Hanaa |e verfasserin |4 aut | |
| 700 | 1 | |a AbdElGawad, Basma |e verfasserin |4 aut | |
| 700 | 1 | |a Deghedy, Ola |e verfasserin |4 aut | |
| 700 | 1 | |a Naguib, Amel |e verfasserin |4 aut | |
| 700 | 1 | |a Roshdy, Wael H |e verfasserin |4 aut | |
| 700 | 1 | |a Showky, Shymaa |e verfasserin |4 aut | |
| 700 | 1 | |a Kamel, Reham |e verfasserin |4 aut | |
| 700 | 1 | |a Elguindy, Nancy |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel Fattah, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Afifi, Salma |e verfasserin |4 aut | |
| 700 | 1 | |a Kandeel, Amr |e verfasserin |4 aut | |
| 700 | 1 | |a Abdelghaffar, Khaled |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Public health in practice (Oxford, England) |d 2020 |g 5(2023) vom: 03. Juni, Seite 100358 |w (DE-627)NLM320213269 |x 2666-5352 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2023 |g day:03 |g month:06 |g pages:100358 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.puhip.2023.100358 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2023 |b 03 |c 06 |h 100358 | ||